Powered by 
Technavio
CTD Holdings | Data-Driven Analysis and Industry Review
Published: August 22, 2024CTD Holdings, Inc. is a biotechnology company focused on the development of Cyclosporine A (CsA) derivative products for the treatment of various diseases. The company's lead product, CTD-102, is a novel, patent-protected, topically-applied formulation of CsA for the potential treatment of psoriasis and other inflammatory skin conditions. CTD Holdings is also exploring the use of CsA in other indications, including ophthalmology, dermatology, and neurology. The company's mission is to bring innovative, effective, and safe treatments to patients suffering from debilitating diseases. CTD Holdings is headquartered in Exton, Pennsylvania, and trades on the OTC Markets under the symbol "CTDH."'
1. CTD Holdings is a biotechnology company focused on the development of Cyclosporine A (CSA) based products for various indications, including neuropathic pain and ocular diseases.
2. The company's lead product, CTD-102, is a proprietary formulation of CSA for the treatment of neuropathic pain in diabetic peripheral neuropathy (DPN), which is in late-stage clinical development.
3. CTD Holdings has a strong intellectual property portfolio, with multiple patents issued or pending for its CSA formulations and delivery systems.
4. The company has a strategic partnership with Sandoz, a Novartis division, for the commercialization of CTD-102 in Europe, Australia, and certain other countries.
5. CTD Holdings is also exploring potential indications for its CSA-based products in ophthalmology, including dry eye disease and retinal diseases, and has initiated a clinical trial for CTD-275, a CSA ophthalmic emulsion, for the treatment of dry eye disease.
1. CTD Holdings specializes in providing business intelligence (BI) solutions that help organizations make data-driven decisions, identify trends, and optimize operations.
2. Their BI offerings include data analytics, reporting, and visualization tools that enable users to access and interpret complex data from various sources.
3. CTD Holdings' BI solutions are designed to be user-friendly, allowing businesses to easily access and understand critical data, enabling faster and more informed decision-making.
4. The company offers customizable solutions to meet the unique needs of different industries and businesses, ensuring that clients receive a solution that fits their specific requirements.
5. CTD Holdings' BI solutions are backed by a team of experts who provide ongoing support and consulting services, ensuring that clients are able to maximize the value of their investment and achieve their business objectives.
Browse Our Research Portfolio In CTD Holdings Markets
Health Care
Pharmaceuticals
Pharmaceuticals
About Technavio
With unparalleled market insights, our research is designed to elevate your business to new heights. Technavio stands at the forefront of market research with a global perspective. Our approach is grounded in four key principles: accessible reports, comprehensive industry analysis, a focus on innovative and emerging technologies, and competitive pricing. We are dedicated to empowering companies and executives to make informed, timely, and strategic decisions.
